Monday Morning Reads

Here is what I'm reading as we kick off the workweek: This Startup Is Developing Finger-Prick Blood Tests, But Don't Call It Theranos 2 (Forbes) The Week Ahead In Biotech: Conferences, Clinical Trial Results, IPOs and More (Benzinga). Azar says 'change is coming' for 340B (BioPharma Dive) This smartwatch with an Uber-like twist is aiming … Continue reading Monday Morning Reads